New nerve block technique may ease pain after heart surgery
NCT ID NCT07259057
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a nerve block called erector spinae plane block (ESPB) can improve pain control and recovery in adults undergoing open-heart surgery. Sixty-six participants received either the nerve block or standard IV opioids. Researchers measured pain scores, need for extra painkillers, and other health indicators for 48 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If it works, this could offer a better way to manage pain after open-heart surgery, reducing opioid use and speeding recovery.
- What could go wrong
- This is a small, completed trial with 66 participants, so results may not apply to everyone. The nerve block carries risks like infection or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
66 people
The number who actually took part.
- Started
-
Jan 2023
- Finished
-
Aug 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 to 75 years * Scheduled for elective open-heart surgery via median sternotomy (CABG or valve surgery) * ASA physical status II-III * Provided written informed consent * BMI \< 35 kg/m² Exclusion Criteria: * Age \<18 or \>75 years * Known coagulopathy or anticoagulation contraindicating regional block * Infection or dermatological lesion at the injection site * Allergy to local anesthetics * Chronic use of opioids, anticonvulsants, antidepressants, or corticosteroids * Significant psychiatric or cognitive disorder preventing cooperation * Severe arrhythmia or hemodynamic instability prior to surgery * Local anesthetic toxicity risk factors or anatomic deformity preventing block placement * Non-elective or emergency cardiac surgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karadeniz Technical University Faculty of Medicine, Farabi Hospital
Trabzon, Trabzon, 61080, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can heart stent patients go home in 6 hours?
- Can a Blood-Pressure reading predict dangerous drops during heart surgery?
- Can AI read heart scans to predict the next heart attack?
- Can a new drug cool the hidden inflammation that fuels heart disease?
- New CT scanner aims to cut unnecessary heart procedures
- Heart bypass surgeons test which vein layout keeps grafts open